Cargando…

P078 Adverse effects of Kaftrio® in an adult cystic fibrosis clinic

Detalles Bibliográficos
Autor principal:	McCabe, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2022
Materias:	Poster Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184769/ http://dx.doi.org/10.1016/S1569-1993(22)00411-8

Ejemplares similares

P245 Kaftrio® Impact and Side-effect Survey (KISS)
por: Holden, A., et al.
Publicado: (2022)

Evaluating the Effect of Kaftrio on Perspectives of Health and Wellbeing in Individuals with Cystic Fibrosis
por: Aspinall, Sean A., et al.
Publicado: (2022)

Delayed hepatic necrosis in a cystic fibrosis patient taking Elexacaftor/Tezacaftor/Ivacaftor (Kaftrio)
por: Salehi, Mahan, et al.
Publicado: (2021)

P175 Extended incubation of cystic fibrosis cultures: is it worth it?
por: Amado, R., et al.
Publicado: (2019)

P075 COVID-19 vaccination uptake in patients with cystic fibrosis
por: Manning, D.-E., et al.
Publicado: (2022)

P074 Post-COVID-19 condition in children with cystic fibrosis
por: Chernyavskaya, A., et al.
Publicado: (2022)

P077 Vaccination of patients with cystic fibrosis during the COVID-19 pandemic in Croatia
por: Markelić, I., et al.
Publicado: (2022)

P076 COVID-19 vaccination in children and adolescents with cystic fibrosis - a single-centre experience
por: Zver, A., et al.
Publicado: (2022)

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population
por: Rosazza, C., et al.
Publicado: (2022)

P256 Change in the anxiety levels of children with cystic fibrosis and their mothers at the beginning of the COVID-19 pandemic and after 1 year
por: Asfuroglu, P., et al.
Publicado: (2022)

P072 SARS-CoV-2 infection in patients with cystic fibrosis (CF) - a single centre experience
por: Vidoevska, A., et al.
Publicado: (2022)

P073 Observed impact on admissions during the COVID-19 pandemic of paediatric cystic fibrosis patients in a tertiary hospital setting
por: Warraich, S., et al.
Publicado: (2022)

EPS1.05 Evaluating impacts of the change from clinic to home spirometry on clinicians and adults with cystic fibrosis
por: Daniels, T., et al.
Publicado: (2021)

ePS4.08 COVID-19 vaccine uptake in adult people with cystic fibrosis
por: Mir, M.H., et al.
Publicado: (2022)

P078 Oral Appliance Fabrication Settings Impact Treatment Efficacy
por: Levendowski, D, et al.
Publicado: (2021)

ePS4.09 COVID-19 vaccination in households of paediatric cystic fibrosis patients - experience of The Cystic Fibrosis Centre in Zagreb, Croatia
por: Bambir, I., et al.
Publicado: (2022)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
por: Scott, E., et al.
Publicado: (2021)

EPS2.04 The role of Flash Glucose Monitoring System at annual review during the COVID-19 restrictions, within Cystic Fibrosis Diabetes Service at Blackpool Adult Cystic Fibrosis Centre, UK
por: Connolly, A., et al.
Publicado: (2021)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

892 Remote monitoring of pregnant and postpartum women with COVID-19
por: McCabe, Meaghan, et al.
Publicado: (2021)

P079 Real-life data on the efficacy and safety of tezacaftor/ivacaftor in people living with cystic fibrosis homozygous for F508del and heterozygous for F508del and a residual function mutation
por: Vincken, S., et al.
Publicado: (2022)

ePS1.06 Evolution of psychological distress during progression of the COVID-19 pandemic in adults with cystic fibrosis
por: Cresta, F., et al.
Publicado: (2022)

ePS4.03 Outcomes of COVID-19 in patients with cystic fibrosis in Wales, UK
por: Lau, D., et al.
Publicado: (2022)

ePS1.02 Long-term psychological impact of COVID-19 on adult patients with cystic fibrosis, including transplanted patients
por: Havermans, T., et al.
Publicado: (2022)

EPS1.06 A retrospective audit of home-based spirometry quality in a large UK adult cystic fibrosis centre
por: Waller, I., et al.
Publicado: (2021)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

ePS4.05 Evolving cystic fibrosis care during COVID-19: a single-centre experience
por: Spoletini, G., et al.
Publicado: (2022)

ePS4.10 Evaluation of possible adverse events in relationship to the SARS-CoV-2 vaccination in cystic fibrosis patients with or without lung transplantation: a retrospective single-centre case series
por: Gautschi, F., et al.
Publicado: (2022)

P078 Predicting initial AutoPAP pressures in children - how do we perform ?
por: Mihai, R, et al.
Publicado: (2022)

ePS1.05 Impact of COVID-19 on mental health among people with cystic fibrosis
por: Chrysochoou, E.-A., et al.
Publicado: (2022)

EPS1.04 Audit of virtual exercise class during COVID-19 in children with cystic fibrosis
por: Johnstone, Z., et al.
Publicado: (2021)

ePS1.04 Sleep disturbances in children with cystic fibrosis at the beginning and in the first year of the COVID-19 pandemic
por: Eyuboglu, T. Sismanlar, et al.
Publicado: (2022)

ePS1.07 Parental experiences of face-to-face versus virtual cystic fibrosis clinics during the COVID-19 pandemic: questionnaire study
por: Lock, K., et al.
Publicado: (2022)

P124 Vaccination situation against COVID-19 in an adults cystic fibrosis center in Argentina
por: Baran, E., et al.
Publicado: (2023)

EPS2.07 How did the COVID-19 lockdown influence the nutritional status and body composition of cystic fibrosis patients in Poland?
por: Mielus, M., et al.
Publicado: (2021)

P095 Effect of age and genotype on lung function in children with cystic fibrosis
por: Shadrina, V., et al.
Publicado: (2021)

ePS4.04 Evaluation of burden of the COVID-19 pandemic among the cystic fibrosis community in Brno, Czech Republic
por: Mala, M., et al.
Publicado: (2022)

EPS4.4 Correlation between long-term changes in LCI, FEV(1) and CFCT score in children with cystic fibrosis
por: Vermeulen, F., et al.
Publicado: (2017)

EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK
por: Brown, C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vrfegelhentqjtbp6flkq4u4u9